Valneva Austria Gmbh

Dynavax Technologies Corporation

Michael Möhlen

Robert Schlegl

Michael Weber

Jürgen Heindl-Wruss

Jürgen Wruss

Andreas Meinke

Robert S Janssen

Christoph Reinisch

David Novack

John Darren Campbell

Christian Taucher

Described herein are CpG-adjuvanted SARS-CoV-2 vaccines and compositions and methods of producing and administering said vaccines to subjects in need thereof.

CpG-adjuvanted SARS-CoV-2 virus vaccine

The invention relates to means and methods for preparing aqueous composition comprising aluminium and a protein said composition comprising less than 700 ppm heavy metal on the basis of weight with respect to the aluminium content. The invention further relates to aqueous compositions comprising a protein and an aluminium-salt, said composition comprising less than 350 ppb heavy metal based on the weight of the aqueous composition.

Aluminum compounds for use in therapeutics and vaccines

Methods for preparing aluminum precipitate compounds for use in therapeutics and vaccines

The invention relates to means and methods for preparing aqueous composition comprising aluminum and a protein said composition comprising less than 700 ppm heavy metal on the basis of weight with respect to the aluminum content. The invention further relates to aqueous compositions comprising a protein and an aluminum-salt, said composition comprising less than 350 ppb heavy metal based on the weight of the aqueous composition.

Growing community of inventors

Vienna, Austria

Michael Möhlen